We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia

This study is currently recruiting participants.
Verified October 2017 by Mendel Tuchman, Children's Research Institute
Sponsor:
ClinicalTrials.gov Identifier:
NCT01599286
First Posted: May 16, 2012
Last Update Posted: October 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Children's Research Institute
Boston Children’s Hospital
University Hospitals Cleveland Medical Center
University of California, Los Angeles
Children's Hospital of Philadelphia
Stanford University
Icahn School of Medicine at Mount Sinai
University of Pittsburgh
Children's Hospital Colorado
Information provided by (Responsible Party):
Mendel Tuchman, Children's Research Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)